Take heed to this text
Xact Robotics introduced that it has acquired FDA clearance for a modification to its Xact Ace robotic system for ablation procedures. Hingham, Massachusetts-based Xact Robotics’ FDA clearance permits for a modification to the already-cleared Xact Ace system, increasing the indication for CT-guided percutaneous procedures for the system designed to help robotic insertion and steering of ablation probes throughout ablation scientific procedures.
In line with a information launch, the Xact Ace robotic system has already been utilized in over 200 scientific instances up to now throughout a number of medical facilities.
The corporate mentioned its Xact Ace system combines image-based process planning and real-time monitoring with hands-free exact robotic insertion and non-linear steering. It creates the potential to save lots of time with quick and correct probe placement.
Xact Ace has achieved a 1.7 mm tip-to-target common accuracy upon first insertion, with lower than an 8.5-minute common skin-to-target time. The corporate mentioned this doubtlessly enhances a consumer’s capacity to offer extra well timed and correct diagnoses and remedy for sufferers, lowering the “watchful ready” interval and enhancing outcomes.
“Ablation procedures are difficult to many customers by way of the accuracy and time required to position the ablation probes,” Xact Robotics founder and Government Chair Harel Gadot mentioned within the launch. “The confirmed capacity of our system to achieve comparatively small targets, no matter goal motion or obstacles, with unparalleled accuracy and one insertion to focus on will present higher affected person outcomes with larger efficiencies. Furthermore, with the addition of the newly cleared ablation capabilities, we will now present much more worth to our companions by growing the utilization of our system.”
XACT Robotics gained a 2022 RBR50 Robotics Innovation Award for its ACE Xtend. The distant management is an add-on answer that enables the corporate’s XACT ACE system for image-guided percutaneous procedures to be operated from a management room at a distance.